drugset

drugset / Trial / NCT00239993

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

NCT00239993 ↗

Phase 4 Completed 50 enrolled Teva Neuroscience, Inc.

RandomizedCrossoverOpen-labelPrevention

Summary

This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

Timeline

Start: 2005-08
Primary completion: 2005-12
Completion: 2006-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Glatiramer Acetate	Small molecule	—	—

Indications